Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC

PHASE2RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

Metastatic Colorectal CancerDrug Therapy

Interventions

DRUG

trifluridine/tipiracil combined with fufuquitinib

DRUG

fufuquitinib

DRUG

Trifluridine/tipiracil

Trial Locations (1)

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors

lead

First Affiliated Hospital of Wenzhou Medical University

OTHER